Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma

The GAUDI study assessed safety and preliminary efficacy of induction therapy with obinutuzumab plus chemotherapy, followed by maintenance therapy with obinutuzumab alone, in previously untreated patients with follicular lymphoma. Assignment to chemotherapy was decided on a per-center basis before t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Haematologica
Main Authors: Grigg, Andrew, Dyer, Martin J.S., Díaz, Marcos González, Dreyling, Martin, Rule, Simon, Lei, Guiyuan, Knapp, Andrea, Wassner-Fritsch, Elisabeth, Marlton, Paula
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2017
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5395117/
https://ncbi.nlm.nih.gov/pubmed/28011903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.152272
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki